Pharmaceutical Business review

Integra to launch new dermal regeneration template in Japan

According to the company, the Integra dermal regeneration template is an advanced bilayer skin replacement system, designed to provide immediate wound closure and permanent regeneration of the dermis.

The Integra dermal regeneration template was the first regenerative product approved by the FDA for the treatment of life-threatening burn and scar revisions, the company said.

Stuart Essig, president and CEO of Integra, said: “We are extremely pleased that our innovative product has been approved in Japan and that Century Medical’s experienced professionals will be handling its distribution. Integra dermal regeneration template has enjoyed broad commercial acceptance around the world and we look forward to entering the Japanese market.”